Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Teva Not Responsible for Hepatitis Outbreak, Lawyer Says

Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, isn’t responsible for a 2008 hepatitis outbreak in Nevada blamed on the misuse of vials of the anesthetic propofol, a lawyer for the company said.

Published
22 August 2011
From
Bloomberg
Some rapid hepatitis C tests have high false-negative rate in people with HIV

Approximately 9% of hepatitis C infections in HIV-positive individuals are missed by some rapid hepatitis C testing assays, US investigators report in the September 15th edition of

Published
22 August 2011
By
Michael Carter
Treatment Action Group publishes Guide to Clinical Trials for People With Hepatitis C

There are many new hepatitis C drugs being studied in clinical trials. People with hepatitis C have many options to choose from. Whether you have hepatitis C or another medical condition, deciding to participate in a clinical trial can be complicated. Having more information can help you decide whether or not to participate in a clinical trial, and which trial, or trials, may be right for you.

Published
17 August 2011
From
Treatment Action Group
UK-Victrelis-Boceprevir HCV Drug Launched

A new pill that directly targets hepatitis C for the first time has been launched in the UK. In clinical trials, adding Victrelis to standard therapy increased the number of chronic patients freed from the virus up to threefold.

Published
10 August 2011
From
Hepatitis C New Drugs blog
Unexplained liver enzyme increases in patients with HIV could be due to hepatitis E virus: screening recommended

Infection with hepatitis E virus should be considered as a possible cause of unexplained elevations in liver enzymes in HIV-positive patients, Swiss investigators suggest in Emerging Infectious Diseases. Approximately

Published
05 August 2011
By
Michael Carter
Injection Drug Users and Adherence to Hepatitis C Treatment

Adherence to hepatitis C treatment was high regardless of injection drug use, a recent Australian study found.

Published
01 August 2011
From
HIV & Hepatitis
Boceprevir response and resistance differs according to HCV genotype 1 subtype

People with hepatitis C virus (HCV) genotype 1b respond better to boceprevir and are less likely to develop drug resistance than those with genotype 1a,

Published
28 July 2011
By
Liz Highleyman
Hepatitis is not just a health issue

World Hepatitis Day recognises the enormous public health challenge viral hepatitis represents and gives us a chance to tackle the stigma around the disease.

Published
28 July 2011
From
The Guardian
WHO: Hepatitis toll 'in millions'

Medical experts are calling for global action to tackle the viruses that cause the liver disease hepatitis, as new figures show it is a significant problem around the world.

Published
28 July 2011
From
BBC Health
Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK™ Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks

today announced interim results from ZENITH, an ongoing Phase 2 study designed to assess the safety, tolerability and efficacy of multiple 12- and 24-week response-guided treatment regimens with VX-222 (400 mg or 100 mg), its lead polymerase inhibitor in development, in combination with INCIVEK™ (telaprevir) tablets, pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment.

Published
27 July 2011
From
Vertex (press release)

Filter by country